Junying Wu

机构：Shanghai Sixth People's Hospital, Fujian Agriculture and Forestry University · ORCID：0009-0004-9841-6537

发表论文 32 篇 · 总被引 239 次 · h-index 9

代表论文

• Comparison of the revised 4th (2016) and 5th (2022) editions of the World Health Organization classification of myelodysplastic neoplasms (2022 · Leukemia · 被引 51)
• IPSS-M has greater survival predictive accuracy compared with IPSS-R in persons ≥ 60 years with myelodysplastic syndromes (2022 · Experimental Hematology and Oncology · 被引 43)
• <i>ASXL1</i> mutations accelerate bone marrow fibrosis via EGR1-TNFA axis-mediated neoplastic fibrocyte generation in myeloproliferative neoplasms (2022 · Haematologica · 被引 26)
• New Insights into the Role of Cellular Senescence and Its Therapeutic Implications in Ocular Diseases (2025 · Bioengineering · 被引 10)
• ASXL1 mutations accelerate bone marrow fibrosis via EGR1-TNFA axis-mediated neoplastic fibrocyte generation in myeloproliferative neoplasms. (2023 · PubMed · 被引 10)
• Ruxolitinib combined with prednisone, thalidomide and danazol in patients with myelofibrosis: Results of a pilot study (2022 · Hematological Oncology · 被引 10)